The understanding that sclerostin blocks the Wnt/β-catenin signaling pathway via BMPs [6, 7], its association with oral diseases such as periodontitis and pulpitis, and its selection as a therapeutic target in studies aimed at establishing effective treatment methods [10] has made it the subject of current research for more detailed evidence. The gene discussed is SOST; the disease is periodontitis.